Prescription Drug Monitoring Program (PDMP)

The Personal CS Prescribing History report is available within Portal in the “Prescriber Reports” tile to prescribers who have a valid DEA number. The purpose of the report is to provide prescribers a listing of their prescriptions across all patients, allowing an opportunity to view and understand their prescribing trends. It can also be used as a tool to audit for potential fraud concerns, for example, if a prescription pad goes missing. The user selects a date range for the report and all prescriptions reported to PDMP attributed to that prescriber’s DEA number will display. (See Example Report)

The report can only be run by a prescriber to see their own history, and security measures are in place to ensure no one can view a report for another prescriber. The first time a user accesses the Personal CS Prescribing History tab, they are required to enter their DEA number. The system verifies the number entered is the same one on record for that user. If the data entered matches the account record, the user can proceed to run the report, and will not have to re-enter the DEA number to access the report in the future. If there is not a match, an error message will appear and the user will be prevented from running the report until the problem is resolved.

This feature currently supports all of the DEA numbers each user is associated with.

For more information about Personal CS Prescribing History, view the following documentation:

1. Maryland Department of Health Clinical Tools Quick Guide
2. Maryland Department of Health PDMP Release for CS Prescribers

Unsolicited Reports are proactive educational notifications to prescribers when outlying patient or prescriber behavior is identified. Unsolicited Reporting is the activity of analyzing PDMP data for an indicator of concern and then proactively reporting PDMP data to a prescriber. These notifications can be mailed or emailed to a prescriber. When an email is sent to a prescriber, they can retrieve the notification in the CRISP Portal using the email address the notification was sent to.

For more information about Unsolicited Reports, view the following documentation:

1. Maryland Department of Health Clinical Tools Quick Guide
2. Maryland Department of Health PDMP Release for CS Prescribers

The Prescriber Insights Report, available in the Prescriber Reports tile of the CRISP Portal, is a clinical tool for a prescriber’s use and benefit to help them monitor their prescribing habits. The data provided by the reports are only shared by CRISP to individual prescribers. By allowing providers to review their prescribing history, CRISP enables providers to see how they are doing in comparison to their peers and provide confidence in how one is prescribing.

The Insight Report includes several measures of a provider’s prescribing practices and displays a comparison to their specialty, provider type, and across Maryland prescribers.

At the top of the report, there are five metrics available, based on a 90-day lookback period from the date indicated. The metrics are as follows:

1. MME, an abbreviation for Morphine Milligram Equivalents, indicates the total number of patients who had at least one day with a dose of 90 or more MME based on all active prescriptions during the 90-day lookback period. You wrote at least one opioid prescription during this time period to a patient that contributed to the patient meeting the 90 or more MME threshold.
2. Opioid Overlap(s) indicates the total number of patients who had 3 or more days of overlapping opioid prescriptions during the 90-day lookback period. You wrote at least one opioid prescription to a patient during this time period that contributed to the patient meeting the overlapping opioid threshold.
3. Benzo & Opioid indicates the total number of patients who had 3 or more days of overlapping opioid and benzodiazepine prescriptions during the 90-day lookback period. You wrote at least one opioid or benzodiazepine prescription to a patient during this time period that contributed to the patient meeting the overlapping threshold.
4. Multiple Provider indicates the total number of patients who received controlled substance (CS) prescriptions from 5 or more prescribers and were dispensed CS medications from 5 or more pharmacies during the 90-day lookback period. You wrote at least one prescription to a patient during this time period that contributed to the patient meeting the multiple provider threshold.
5. Long-Term Opioid Use indicates patients who had greater than or equal to 60 days of consecutive opioid prescriptions during the 90-day lookback period. You wrote at least one prescription during this time period to that patient that contributed to the patient meeting the long=term opioid use threshold.

The “Prescriber Comparison” section at the bottom of the report allows prescribers to compare their prescription history data to others. To utilize the comparison section, users must select a month, Drug Group, and Comparison Group for the data.

1. Select a Month: Note that only one month of data will display at a time. You can choose a specific month to view from the dropdown list. Date is based on day the prescription was written.
2. Select a Drug Group: You may choose a specific drug group or combination of groups to view. Simply click on a drug group to include that group. The default includes all the drug groups. You may select multiple groups at the same time. The ‘Opioid’ drug group excludes buprenorphine containing products that have an FDA indication for treatment of substance use disorder. The ‘Bup for Treatment’ only includes buprenorphine containing products that have an FDA indication for treatment of substance use disorder.
3. Select a Comparison: You may choose a specific comparison group or compare to all other Maryland prescribers.

For more information about the Prescriber Insights Report, view the following documentation:

1. Maryland Department of Health PDMP Release for CS Prescribers
2. Maryland Department of Health Prescriber Insights Report Booklet
3. CRISP Prescriber Insights User Guide
4. CRISP Prescriber Insights Frequently Asked Questions

The Buprenorphine Comparison Report, available through the Prescriber Reports tile in the CRISP Portal, lists the number of patients receiving buprenorphine for substance user disorder treatment formulas with a comparison to peers.

This report provides a summary of the past 60 days of PDMP dispense data for prescriptions written for formulations of buprenorphine that are approved by the FDA to be used to treat opioid use disorder (OUD). Prescribers can view both the number of patients for whom they prescribe buprenorphine compared to their peers as well as the number of patients over time.

For more information about the Buprenorphine Comparison Report, view the MDH Prescriber Buprenorphine Comparison Report Quick Guide.